首页 正文

The benefits of trastuzumab in the treatment of HER2+ breast cancer as a function of exposure time

{{output}}
Background: Breast cancer is a heterogeneous disease with overexpression of several receptors, such as human epidermal receptor 2 (HER2), which is a prognostic and predictive biomarker for treatment with the anti-HER2 monoclonal ... ...